参考文献/References:
[1] Gao R, Cao B, Hu Y, et al. Human infection with a novel avianorigin influenza A (H7N9) virus.[J]. New England Journal of Medicine, 2013,368(20):1888.
[2] 郭雅玲, 马羽萍, 许荣放, 等. 甲型H1N1流感1363例临床特点分析[J]. 陕西医学杂志, 2011,40(10):13461348.
\[3\] Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection.[J]. N Engl J Med, 2013,368(24):22772285.
\[4\] 国家卫生和计划生育委员会. 人感染H7N9禽流感诊疗方案(2017年第1版)[J]. 中国病毒病杂志, 2017,30(1):14.
\[5\] Xunbo DU, Yang L, Yue Y, et al. Survey report on the first case of human infection of H5N1 avian influenza in Chengdu in 2016[J]. Journal of Preventive Medicine Information, 2018,34(2):2023.
[6] Yang ZF, Mok CK, Peiris JS, et al. Human infection with a novel avian influenza A(H5N6) virus[J]. N Engl J Med, 2015,373(5):487489.
[7] Liu D, Shi W, Shi Y, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses[J]. Lancet, 2013,381(9881):19261932.
[8] 王琦梅, 刘社兰, 陈恩富. 人感染H7N9禽流感流行病学研究进展[J]. 中华预防医学杂志, 2017,51(2):183187.
[9] 任瑞琦, 周 蕾, 向妮娟, 等. 中国内地人感染H7N9禽流感疫情流行病学特征分析[J]. 中华流行病学杂志, 2014,35(12):13621365.
[10] 王逸平, 赵宏胜. 人感染H7N9禽流感重症病例3例临床特点分析[J]. 南通大学学报:医学版, 2017,37(2):132135.
[11] 夏洪韬, 曹 霖, 何正光, 等. 四川省首发六例人感染H7N9禽流感重症患者的临床特征分析[J]. 中国呼吸与危重监护杂志, 2017,16(2):103108.
[12] Chen Y, Liang W, Yang S, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome[J]. Lancet, 2013,381(9881):19161925.
[13] Liu CX, Laboratory DO. Molecular biology diagnostic technique of H7N9 avian influenza virus[J]. Occupation & Health, 2018,(2):143146.
[14] 林丽雅, 陈聚兴, 伍尚剑, 等. H7N9禽流感患者生化指标的临床价值研究[J]. 实用医技杂志, 2016,23(8):824826.
[15] 陈聚兴, 陈瑞丽, 伍尚剑. 感染性指标对人感染H7N9禽流感的诊疗价值研究[J]. 中国实用医药, 2016,11(20):9294.
[16] 陆普选, 曾 政, 郑斐群, 等. 人感染H7N9禽流感病毒性重症肺炎的影像学表现及动态变化特点[J]. 放射学实践, 2014,29(7):740744.
[17] 谢 陈. 人感染H7N9 禽流感病毒的胸部影像学表现[J]. 实用医院临床杂志, 2018,(3):205207.
[18] Sartori S, Tombesi P. Emerging roles for transthoracic ultrasonography in pulmonary diseases[J]. World Journal of Radiology, 2010,2(6):203214.
[19] Reissig A, Copetti R, Mathis G, et al. Lung ultrasound in the diagnosis and followup of communityacquired pneumonia: a prospective, multicenter, diagnostic accuracy study[J]. Chest, 2012,142(4):965972.
[20] Americo T, Gino S, Roberto C, et al. Early recognition of the 2009 pandemic influenza A (H1N1) pneumonia by chest ultrasound[J]. Critical Care, 2012,16(1):R30.
[21] 沈 鹏, 宗酉明, 殳 儆, 等. 超声在评估人感染H7N9禽流感肺部病变中的应用[J]. 中华急诊医学杂志, 2014,23(2):224226.
[22] Liu Y, Cai S, Huang H, et al. Application of pulmonary ultrasound in severe human infection with H7N9 avian influenza[J]. China Medicine & Pharmacy, 2018,8(5):2325,46.
[23] 李 丹, 谭 琴, 龙云铸. 抗病毒与免疫调节治疗H7N9禽流感研究进展[J]. 中国感染控制杂志, 2015,14(10):717720.
[24] Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor flu treatment investigator group[J]. Lancet, 2000,355(9218):18451850.
[25] Chen H Y, Zhang J. Effect of combination with the thymosin alpha 1 in elderly severe pneumonia[J]. Modern Medical Journal, 2013,50(4):4144.
[26] Mingxia JI, Xiaoshui SI, Jianxin HE. Efficacy of thymosinα1 for patients with severe pneumonia[J]. Zhejiang Medical Journal, 2015,37(9):738740.
[27] Confalonieri M, Meduri GU. Glucocorticoid treatment in communityacquired pneumonia[J]. Lancet, 2011,377(9782):19821984.
[28] 姚贵江, 姜 娟. 无创机械通气在危重症甲型H1N1流感并呼吸衰竭中的疗效[J]. 中国临床研究, 2013,26(3):225226.